ADVFN - Advanced Financial Network.
HOME» NYSE » N » NVS Stock Price » NVS Stock News

Novartis Share News

 Novartis Ag Basel Stock Price
NVS Stock Price
 Novartis Ag Basel Stock Chart
NVS Stock Chart
 Novartis Ag Basel Stock News
NVS Stock News
 Novartis Ag Basel Company Information
NVS Company Information
 Novartis Ag Basel Stock Trades
NVS Stock Trades

WSJ BLOG/Health: A.M. Vitals: Study Shows Cancer Risk for Children Getting CT Scans

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Mark Long Here's what's making health news this morning: Children's CT Scans Pose Cancer Risk (WSJ): Getting two to three computed tomography head exams makes children and adolescents three times as likely to develop brain cancer--though the absolute risk is small--a study of 176,587 people published in The Lancet showed. DNA Blueprint for Fetuses Built Using Tests of Parents (New York Times): Scientists reported in a paper in Science Translational Medicine that they used new, high-speed sequencing and computational tools to deduce the DNA sequence of the fetus using a blood sample from the pregnant woman and saliva from the father. New Cancer-Gene Test Seeks to Match Drugs to Patients (WSJ): Foundation Medicine disclosed that Novartis will use its new test to genetically analyze tumors in most patients in early stage clinical trials of the Swiss drug maker's experimental treatments. Novartis Unit Recalling Birth Control Pills (WSJ): The FDA said the unit, Sandoz, is recalling 10 lots of the Introvale pills sold in the U.S. because of a packing error. Vaccines for U.S. Children May Not Be Properly Stored--Study (Reuters): A report from the Office of the Inspector General in the Department of Health and Human Services found free vaccines meant for kids in a federal program may have been stored at the wrong temperature. FDA Approves Glaxo, XenoPort Drug Horizant for Shingles-Related Disease (Dow Jones Newswires): Approval of the drug to manage postherpetic neuralgia, which affects about 100,000 Americans, follows three clinical studies involving 574 adults. First Tuberculosis Drug in 40 Years Has Otsuka Cautious (Bloomberg News): A study published in the New England Journal of Medicine shows the Japanese company's delamanid helped fight TB strains not halted by other treatments. Otsuka plans to restrict access to avoid resistance to the drug building up. -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

Stock News for Novartis (NVS)
DateTimeHeadline
03/16/201703:58:00Oxford Biomedica Loss Widens, Sees Progress in 2017
03/02/201708:16:00Novartis Fined by South Korea Over Alleged Kickbacks
02/08/201706:00:00Propeller Health Enters into Collaboration to Connect Breezhaler™ D...
01/31/201714:59:00Trump Tells Pharmaceutical CEOs He Wants Prices Down -- Update
01/26/201703:02:00Novartis Weighs Alcon Spinoff -- WSJ
01/25/201705:28:00Vectura Group Says Bronchitis Inhaler Sales Trigger Milestone...
01/25/201703:42:00Novartis May Spin Off |Alcon Eye-Care Business
01/25/201701:51:00Novartis Announces Share Buyback as Dollar Hits Earnings
01/13/201716:21:00Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech...
01/06/201713:06:00Correction to Novartis to Pay Up to $1.6 Billion to Ionis
01/06/201706:17:00Novartis to Pay Up to $1.6 Billion to Ionis, Unit for Rights...
10/27/201616:40:00Amgen Sees Profit Increase, Raises Guidance
10/25/201604:40:00Novartis Profit Helped by GlaxoSmithKline Joint Venture
10/25/201603:53:00Novartis Profit Helped by GlaxoSmithKline Joint Venture -- Update
10/25/201602:01:00Novartis Net Income Rose in 3rd Quarter
10/21/201608:14:00Novartis AG 3Q 2016 - Forecast
10/05/201608:20:00Eli Lilly to Buy Boehringer Ingelheim Pet Vaccines Portfolio
10/02/201623:40:00Novo Nordisk Bets on Riskier Insulin Research
09/23/201613:11:00Novartis receives three new FDA approvals for the expanded use...
08/30/201618:50:00FDA Approves Novartis's Biosimilar to Amgen's Enbrel

Novartis and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US